# A Study of the Effects of Oral Prednisone in Patients With Rheumatoid Arthritis (MK0000-088)

> **NCT00746512** · PHASE1 · COMPLETED · sponsor: **Merck Sharp & Dohme LLC** · enrollment: 45 (actual)

## Conditions studied

- Rheumatoid Arthritis

## Interventions

- **DRUG:** Prednisone 15 mg
- **DRUG:** Placebo Tablets
- **DRUG:** Prednisone 7.5 mg
- **DRUG:** Placebo Over-Encapsulated Tablets

## Key facts

- **NCT ID:** NCT00746512
- **Lead sponsor:** Merck Sharp & Dohme LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-09
- **Primary completion:** 2009-09
- **Final completion:** 2009-09
- **Target enrollment:** 45 (ACTUAL)
- **Last updated:** 2015-05-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00746512

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00746512, "A Study of the Effects of Oral Prednisone in Patients With Rheumatoid Arthritis (MK0000-088)". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00746512. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*